Advanced search×

Proofs of some simplified characterizations of the ground states of spin-1 Bose-Einstein condensates

arXiv:1102.0832 [math-ph] 4 Feb 2011

We justify some characterizations of the ground states of spin-1 Bose-Einstein condensates exhibited from numerical simulations. For ferromagnetic systems, we show the validity of the single-mode approximation (SMA). For an antiferromagnetic system with nonzero magnetization, we prove the vanishing of the $m_F=0$ component. In the end of the paper some remaining degenerate situations are also discussed. The proofs of the main results are all based on a simple observation, that a redistribution of masses among different components will reduce the kinetic energy.

Version: za2963e q8zaa q8zb2 q8zc0 q8zd6 q8ze1 q8zfc q8zg3

Similar articles you may find interesting…

  1. Amino acid substitution in the active site of DNA polymerase β explains the energy barrier of the nucleotidyl transfer reaction.

    J Am Chem Soc (2013) PMID 23647366

    We have proposed that a nearby carboxylate group of Asp256 enables the reaction by accepting a proton from the primer O3´group, thus activating O3´as the nucleophile in the reaction path. Here, we tested this proposal by altering the side chain of Asp256 to Glu and then exploring the impact of thi...
  2. Highly Potent Inhibitors of Quorum Sensing in Staphylococcus aureus Revealed Through a Systematic Synthetic Study of the Group-III Autoinduc...

    J Am Chem Soc (2013) PMID 23647400

    We seek to expand this set of chemical probes, and report herein the first design, synthesis, and biological testing of AIP-III mimetics. A set of non-native peptides was identified that can inhibit all four of the AgrC receptors (I-IV) with picomolar IC50 values in reporter strains. These analogs a...
  3. Demonstration of the Innate Electrophilicity of 4-(3-(Benzyloxy)phenyl)-2-(ethylsulfinyl)-6-(trifluoromethyl)pyrimidine (BETP), a Small Mole...

    Drug Metab Dispos (2013) PMID 23653442

    4-(3-(Benzyloxy)phenyl)-2-(ethylsulfinyl)-6-(trifluoromethyl)pyrimidine (BETP) represents a novel small molecule activator of the glucagon-like peptide-1 receptor (GLP-1R), and exhibits glucose-dependent insulin secretion in rats following intravenous (but not oral) administration. I...